In recent months, the landscape of influenza vaccine strategies has changed, with the live-attenuated nasal spray vaccine losing its status as a recommended vaccine against influenza after showing low efficacy rates in the most recent flu season. Newly published data in the Annals of Internal Medicine, however, add to the nuances of influenza vaccine recommendations.
OSAP Disclaimer | Please notify our webmaster of any problems with this website. OSAP thanks its Super Sponsors for their support in 2016. Sponsorship does not imply endorsement by OSAP of a company's products or services.